If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
305.00    -8.00 (-2.56%)
Bid:
300.00
Ask:
310.00
Spread: 10.00 (3.333%)
Market Cap: £38.70m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Grant of Options

29 Oct 2021 13:24

RNS Number : 7689Q
System1 Group PLC
29 October 2021
 

29th October 2021

System1 Group PLC (AIM: SYS1)

("System1" or "the Company")

 

 

Grant of Options

 

Following approval by shareholders at the Company's 2021 Annual General Meeting for certain amendments to the System1 Long Term Incentive Plan (the "LTIP") the Company announces that on 27 October 2021 it granted awards under the LTIP.

 

In aggregate, awards (structured as nil cost options) were granted to a number of executives over 793,603 ordinary shares of the Company, of which 645,314 replaced options awarded under the previous arrangements and 148,289 were new awards.

 

The replacement awards include nil cost options which were granted over an aggregate of 132,267 shares to Chris Willford (the "grantee") the Company's Chief Financial Officer. The nil cost options replace an option which was made to the grantee on 27 November 2020 under the LTIP which has been surrendered by the grantee.

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Chris Willford

2.

Reason for the notification

a)

Position / status

Chief Financial Officer

b)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

System1 Group PLC

b)

LEI

213800TDLR42C3Q9ZB74

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Option over ordinary shares

b)

Nature of the transaction

Surrender of option

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

nil

132,267 shares

 

 

d)

Aggregated information

- Aggregated volume

- Price

 

 

Not applicable - single transaction

e)

Date of the transaction

27 October 2021

f)

Place of the transaction

Outside a trading venue

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Chris Willford

2.

Reason for the notification

a)

Position / status

Chief Financial Officer

b)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

System1 Group PLC

b)

LEI

213800TDLR42C3Q9ZB74

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Options over ordinary shares

b)

Nature of the transaction

Grant of LTIP Awards

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

nil

132,267 shares

 

 

d)

Aggregated information

- Aggregated volume

- Price

 

 

Not applicable - single transaction

e)

Date of the transaction

27 October 2021

f)

Place of the transaction

Outside a trading venue

The Company can be found at www.system1group.com.

For further information please contact:

 

System1 Group PLC

 

+44 (0)20 7043 1000

 

John Kearon, Founder and Executive President

Chris Willford, Chief Financial Officer

 

Canaccord Genuity Limited +44 (0)20 7523 8000

Simon Bridges / Andrew Potts

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFEDFEUEFSEES
Date   Source Headline
8th Jul 20264:15 pmRNSDividend Timetable
8th Jul 20267:00 amRNSFinal Results
2nd Jul 20267:00 amRNSNotice of Investor Presentation
1st May 20264:30 pmRNSHolding(s) in Company
21st Apr 20267:01 amRNSRelationship Agreement with Brave Bison
21st Apr 20267:00 amRNSQ4 and Full Year Trading Update
9th Apr 20267:00 amRNS-RLaunch of next evolution of Test Your Ad platform
30th Mar 20264:30 pmRNSHolding(s) in Company
30th Mar 20263:30 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSTrading Update
16th Mar 20267:00 amRNSTrading Update
5th Mar 20263:15 pmRNSDirector/PDMR Shareholding
3rd Mar 20265:15 pmRNSHolding(s) in Company
3rd Mar 20264:06 pmRNSBoard Change
2nd Mar 20261:39 pmRNSShareholder update & PDMR Dealing
2nd Mar 20267:00 amRNSDirectorate change
30th Jan 20261:00 pmRNSBoard Committee and Change of Role Update
20th Jan 20267:00 amRNSTrading Update
12th Jan 20264:45 pmRNSAppointment of Joint Corporate Broker
2nd Dec 20257:00 amRNSInterim Results
20th Nov 202511:45 amRNSHolding(s) in Company
24th Oct 20253:28 pmRNSHolding(s) in Company
22nd Oct 20257:00 amRNSTrading Update
14th Oct 20259:16 amRNSCapital Markets Day
6th Oct 20253:30 pmRNSDirector/PDMR Shareholding
30th Sep 20257:00 amRNSDirector/PDMR Shareholding - replacement
29th Sep 20255:48 pmRNSDirector/PDMR Shareholding
29th Sep 20251:27 pmRNSHolding(s) in Company
26th Sep 20252:29 pmRNSHolding(s) in Company
26th Sep 20257:00 amRNSDirector/PDMR Shareholding
24th Sep 20253:01 pmRNSResult of AGM
23rd Sep 20257:00 amRNSTrading Update
15th Sep 20251:00 pmRNSDirector/PDMR Shareholding
27th Aug 20254:51 pmRNSNotice of AGM
8th Aug 20254:35 pmRNSDirector/PDMR Shareholding
9th Jul 20257:00 amRNSDirector Role Change
9th Jul 20257:00 amRNSFinal Results
9th Jul 20257:00 amRNSTrading Update
4th Jul 202511:45 amRNSHolding(s) in Company
4th Jul 20257:00 amRNSHolding(s) in Company
16th Jun 20251:30 pmRNSHolding(s) in Company
14th May 20257:00 amRNSEstablishment of New Long-Term Incentive Plan
24th Apr 20251:53 pmRNSHolding(s) in Company
23rd Apr 20257:00 amRNSTrading Statement
23rd Jan 20257:00 amRNSHolding(s) in Company
21st Jan 20257:00 amRNSTrading Update
8th Jan 202510:15 amRNSHolding(s) in Company
3rd Dec 20247:00 amRNSInterim Results
28th Nov 20247:00 amRNSInterim Results Presentation
21st Nov 20243:31 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.